Developed by our university's Faculty of Medicine Department of Basic Medicine faculty member Assoc. Prof. Ahmet EKEN and Dr. Zehra Büşra AZİZOĞLU, post-doc researcher from the Genome and Stem Cell Center, the national patent titled "Use of Recombinant Human Reg1a Protein in the Treatment of Multiple Sclerosis," has been registered by the Turkish Patent and Trademark Office.

We congratulate our researchers, and wish them continued success.